AstraZeneca Pushes Into GI Cancers With HIMALAYA And TOPAZ-1

Not Quite At The Summit But Tremelimumab Hits A High

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.